A detailed history of Fort, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Fort, L.P. holds 1,776 shares of ABBV stock, worth $319,680. This represents 0.91% of its overall portfolio holdings.

Number of Shares
1,776
Previous 1,904 6.72%
Holding current value
$319,680
Previous $326,000 7.36%
% of portfolio
0.91%
Previous 0.85%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $20,971 - $25,514
-128 Reduced 6.72%
1,776 $350,000
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $7,894 - $9,218
51 Added 2.75%
1,904 $326,000
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $44,429 - $50,623
-278 Reduced 13.05%
1,853 $337,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $5,477 - $6,340
41 Added 1.96%
2,131 $317,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $5,697 - $7,090
-43 Reduced 2.02%
2,090 $281,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $111,928 - $128,901
-774 Reduced 26.63%
2,133 $339,000
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $140,108 - $168,026
-1,013 Reduced 25.84%
2,907 $470,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $391,490 - $449,013
-2,917 Reduced 42.66%
3,920 $526,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $698,146 - $887,572
-5,073 Reduced 42.59%
6,837 $1.05 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $180,020 - $223,355
-1,364 Reduced 10.28%
11,910 $1.93 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $123,437 - $156,183
-1,149 Reduced 7.97%
13,274 $1.8 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $173,644 - $197,112
-1,632 Reduced 10.17%
14,423 $1.56 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $170,966 - $190,466
-1,625 Reduced 9.19%
16,055 $1.81 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $30,485 - $33,560
298 Added 1.71%
17,680 $1.91 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $287,671 - $388,386
3,574 Added 25.88%
17,382 $1.86 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $102,232 - $119,987
1,190 Added 9.43%
13,808 $1.21 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $1.56 Million - $2.08 Million
-21,221 Reduced 62.71%
12,618 $1.24 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $133,450 - $202,327
2,069 Added 6.51%
33,839 $2.58 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $891,454 - $1.12 Million
12,359 Added 63.67%
31,770 $2.81 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $750,658 - $902,506
11,919 Added 159.09%
19,411 $1.47 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $327,514 - $418,640
4,985 Added 198.84%
7,492 $545,000
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $189,918 - $223,524
2,462 Added 5471.11%
2,507 $202,000
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $11,443 - $14,113
-147 Reduced 76.56%
45 $4,000
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $17,070 - $18,977
192 New
192 $18,000
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $1.92 Million - $2.28 Million
-21,421 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $6.95 Million - $9.3 Million
-75,491 Reduced 77.9%
21,421 $2.03 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $3.03 Million - $3.32 Million
-33,785 Reduced 25.85%
96,912 $9.37 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $9.13 Million - $11.7 Million
130,697
130,697 $11.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fort, L.P. Portfolio

Follow Fort, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.